Drug intelligence / Profile preview

anti-FGFR3 scFv 3C

Development stage
Preclinical
Modality
scFv Fragments → Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

anti-FGFR3 scFv 3C is a **human single-chain variable fragment antibody (scFv)** that specifically targets the extracellular domain of **fibroblast growth factor receptor 3 (FGFR3)**. Isolated via phage display from a human naïve scFv library, it demonstrates high specificity for FGFR3—including both wild-type and activated mutant forms (notably the S249C mutation common in bladder cancer)—with minimal cross-reactivity to related FGFR family members. The 3C scFv blocks FGFR3/Fibroblast Growth Factor 9 (FGF9) interactions and inhibits FGFR3-mediated signaling, leading to dose-dependent inhibition of proliferation in FGFR3-mutant bladder carcinoma cells. Its evidence base supports use as a preclinical antitumor agent in bladder cancer models[3].

Other names
3C scFv
02

Targets

FGFR3 (Fibroblast growth factor receptor 3)

Beyond the preview

Go deeper on anti-FGFR3 scFv 3C.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on anti-FGFR3 scFv 3C.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call